Error: Could not add to watchlist. X

Ikaria Inc

+ Watchlist
IKAR:US
Unlisted
IKAR:US is unlisted
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Ikaria, Inc. operates as a biotherapeutics company. The Company offers acute care therapies for critically ill patients, utilizes science to develop biotherapeutic solutions for the critical care market, as well as provides inhalation treatments for patients with hypoxic respiratory failure associated with clinical evidence of pulmonary hypertension.
ADDRESS
Perryville III Corporate Park
53 Frontage Road, PO Box 9001
Hampton, NJ 08827-9001
United States
PHONE
1-908-238-6600
  • Daniel Tasse
    Chairman/President/CEO
  • Douglas Greene
    Exec VP:Research & Development
  • Anastasios G Konidaris "Tasos"
    Senior VP/CFO
  • James Briggs
    Senior VP:Human Resources
  • Stephen A Ross
    Senior VP: Commercial Operation
Show More